Humanized mouse models for human viral hepatitis and related liver diseases
Xiaonan Ren,Xiaohui Zhou
DOI: https://doi.org/10.1360/n972019-00303
2019-06-13
Chinese Science Bulletin
Abstract:Liver diseases, such as viral hepatitis and related fibrosis, cirrhosis and hepatocellular carcinomas, greatly threaten the health of human beings and constitute a global health problem. Nevertheless, suitable animal models of human liver diseases, especially for hepatitis virus infections, are not yet successfully established to avoid the defects of the traditional animal models. Take hepatitis B virus (HBV)and hepatitis C virus (HCV) for examples, most of the existing experimental animals except chimpanzee and Tupaia belangeri, cannot form a natural infection of these two hepatitis viruses, because of the stringent host species barrier to the infection. Human and chimpanzee hepatocytes are natural target cells for HBV and HCV infections and susceptible to infections of these two hepatitis viruses, which suggests that virus-specific receptors on the surface of these hepatocytes, as well as the intrinsic cellular circumstances, can support the initiation of the infection and the whole intracellular life cycle of hepatitis B and C viruses. Therefore, although chimpanzee is a costly animal model, it was used to study HBV and HCV infections and host immunological responses, especially to analyze natural and adaptive immune responses to infection. Though regarded as a high standard non-human primate model for hepatitis virus infection, chimpanzees have already been banned to use for experiments in Europe and the United States because of ethical concerns. Mice are convenient and cheap laboratory animals, but they cannot be infected by HBV naturally. Transgenic mice expressing partial or complete viral genomes are useful to study viral replication, yet the viral life cycles are incomplete and virus-host interaction, especially the host immunological responses against the viruses, cannot be investigated due to the immunological tolerance to the transgenes. To overcome these limitations, humanized mouse models have been developed. Humanized mouse models, in which the liver is engrafted with human hepatocytes, can veritably mimic human infection cases, and thus play important roles in the research on human viral hepatitis and related liver diseases. They can be applied also to evaluate vaccination strategies, drug metabolism, personalized medical treatment, hence has become a popular option of pre-clinical animal models. The development of humanized mouse models for liver diseases have gone through several stages, from human liver chimeric mouse (e.g., uPA/SCID, FRG, TK-NOG, and Alb-TRECK/SCID) to humanized liver and immune system double chimeric mouse (e.g., AFC8, FRGN, uPA/NOG, and FRGS), and further to hepatitis virus-infected models based on these humanized mice. So far, humanized mouse models represent the summit models for the in vivo studies of hepatitis virus infections. These humanized mouse models have their advantages and disadvantages, which should be carefully assessed on the basis of the specific research aims. This review summarizes several important humanized mouse models which are used in the field of human liver disease researches. Great progress has been made in humanized mouse models over the past years, however, these models are still under development. In the future, better-humanized mouse models can be anticipated for further research of antiviral treatments, virus-host interactions and novel immunotherapies for human liver diseases.